These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 4370974)

  • 21. Design, synthesis, and biological activities of new thieno[3,2-d] pyrimidines as selective type 4 phosphodiesterase inhibitors.
    Crespo MI; Pagès L; Vega A; Segarra V; López M; Doménech T; Miralpeix M; Beleta J; Ryder H; Palacios JM
    J Med Chem; 1998 Oct; 41(21):4021-35. PubMed ID: 9767640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.
    Cohan VL; Showell HJ; Fisher DA; Pazoles CJ; Watson JW; Turner CR; Cheng JB
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1356-61. PubMed ID: 8819523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea.
    Ellis JL; Conanan ND
    J Pharmacol Exp Ther; 1995 Mar; 272(3):997-1004. PubMed ID: 7891355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Muscular blood flow during inhibition of 3', 5'-AMP-phosphodiesterase. Clinical and experimental studies using 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine].
    Köhler M
    Arzneimittelforschung; 1973 Apr; 23(4):566-70. PubMed ID: 4351130
    [No Abstract]   [Full Text] [Related]  

  • 25. 3-Substituted 5,7-dimethylpyrazolo(1,5-a)pyrimidines, 3',5'-cyclic-AMP phosphodiesterase inhibitors. 1.
    Novinson T; Hanson R; Dimmitt MK; Simon LN; Robins RK; O'Brien DE
    J Med Chem; 1974 Jun; 17(6):645-8. PubMed ID: 4364336
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative studies on distribution and properties of carbonyl reductase in mammalian tissues.
    Sawada H; Hara A; Nakayama T; Usui S; Hayashibara M
    Prog Clin Biol Res; 1982; 114():275-89. PubMed ID: 6819585
    [No Abstract]   [Full Text] [Related]  

  • 27. [Inhibitory action of newly synthesized 1,3-dimethylxanthine derivatives on the 3',5'-cyclic AMP phosphodiesterase activity of the homogenates of various tissues].
    Staneva D; Bogoslovova T; Pankova A
    Eksp Med Morfol; 1980; 19(3):154-9. PubMed ID: 6252004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M; Cover PO; Poyser RH; Buckingham JC
    Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
    Miot F; Erneux C; Wells JN; Dumont JE
    Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea pig airways in vivo.
    Raeburn D; Karlsson JA
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1147-52. PubMed ID: 8263775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological activity of some 2' derivatives of adenosine 3',5'-cyclic phosphate.
    Miller JP; Shuman DA; Scholten MB; Dimmitt MK; Stewart CM; Khwaja TA; Robins RK; Simon LN
    Biochemistry; 1973 Feb; 12(5):1010-6. PubMed ID: 4346920
    [No Abstract]   [Full Text] [Related]  

  • 32. CDP840: a novel inhibitor of PDE-4.
    Perry MJ; O'Connell J; Walker C; Crabbe T; Baldock D; Russell A; Lumb S; Huang Z; Howat D; Allen R; Merriman M; Walls J; Daniel T; Hughes B; Laliberte F; Higgs GA; Owens RJ
    Cell Biochem Biophys; 1998; 29(1-2):113-32. PubMed ID: 9631241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On the occurrence and activity of xylitol:NADO-oxidoreductase (L-xylulose-forming) in vertebrates].
    Hollmann S; Laumann G
    Hoppe Seylers Z Physiol Chem; 1967 Aug; 348(8):1073-6. PubMed ID: 5627949
    [No Abstract]   [Full Text] [Related]  

  • 34. Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines.
    Mushlin P; Boerth RC; Wells JN
    Mol Pharmacol; 1981 Jul; 20(1):179-89. PubMed ID: 6270531
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of reduced myocardial cyclic AMP content on the response to milrinone in the isolated guinea pig heart.
    Kehler CH; Hebl JR; Soule CL; Gallagher WJ; Houlton AJ
    J Heart Lung Transplant; 1997 Jun; 16(6):636-42. PubMed ID: 9229294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries.
    Birk S; Edvinsson L; Olesen J; Kruuse C
    Eur J Pharmacol; 2004 Apr; 489(1-2):93-100. PubMed ID: 15063160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Divergent actions of protein kinase modulator in regulating mammalian cyclic GMP-dependent and cyclic AMP-dependent protein kinases.
    Kuo JF
    Metabolism; 1975 Mar; 24(3):321-9. PubMed ID: 165354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in the activity of respiratory enzymes in animals with various radiosensitivities].
    Balmukhanov SB; Uteshev AB; Abdrakov BK; Satkhozhina EA
    Radiobiologiia; 1969; 9(3):373-7. PubMed ID: 5356092
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro effects of organic mercury compounds on glutmminase activity of various organs in guinea pigs.
    Takahama K
    Kumamoto Med J; 1970 Sep; 23(3):85-91. PubMed ID: 5515479
    [No Abstract]   [Full Text] [Related]  

  • 40. Detection of guanyl cyclase in mammalian tissues.
    White AA; Aurbach GD
    Biochim Biophys Acta; 1969; 191(3):686-97. PubMed ID: 4312210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.